secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aptorum Group Ltd (APM)
CIK:        0001734005
Form:       8-K
Filed at:   2026-08-21T21:00:33+00:00
Accession:  0001213900-26-092661
Event type: earnings
Sentiment:  negative
Materiality: 0.80
Item codes: 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Niki BioSolutions posts H1 2026 net loss of $1.3M, flags going-concern doubt
----------------------------------------------------------------------------

- H1 2026 net loss attributable to Niki was $1,326,004 vs $441,780 in H1 2025; EPS loss of $1.6.
- Cash fell to $1,834,171 from $3,452,891 at Dec 31, 2025; operating cash outflow of $1,553,720.
- Management disclosed substantial doubt about going concern within next 12 months; negative working capital of $2,475,418.
- R&D expenses rose to $383,752 from $19,375 in H1 2025; related-party convertible notes total $3,508,500.
- 1-for-10 reverse stock split effective July 20, 2026; 1,979,216 shares issued to DiamiR stockholders.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1734005/000121390026092661/0001213900-26-092661-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1734005/000121390026092661/ea0302544-8k_nikibio.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-092661

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer